Delcath Systems
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.About DCTH
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO.
CEOGerard J. Michel
CEOGerard J. Michel
Employees96
Employees96
HeadquartersQueensbury, New York
HeadquartersQueensbury, New York
Founded1988
Founded1988
Employees96
Employees96
DCTH Key Statistics
Market cap383.90M
Market cap383.90M
Price-Earnings ratio1.28K
Price-Earnings ratio1.28K
Dividend yield—
Dividend yield—
Average volume501.64K
Average volume501.64K
High today$11.25
High today$11.25
Low today$10.79
Low today$10.79
Open price$10.95
Open price$10.95
Volume48.02K
Volume48.02K
52 Week high$18.23
52 Week high$18.23
52 Week low$8.12
52 Week low$8.12
Stock Snapshot
Delcath Systems(DCTH) stock is priced at $10.87, giving the company a market capitalization of 383.9M. It carries a P/E multiple of 1276.74.
On 2026-01-23, Delcath Systems(DCTH) stock traded between a low of $10.79 and a high of $11.25. Shares are currently priced at $10.87, which is +0.8% above the low and -3.4% below the high.
Delcath Systems(DCTH) shares are trading with a volume of 48.02K, against a daily average of 501.64K.
In the last year, Delcath Systems(DCTH) shares hit a 52-week high of $18.23 and a 52-week low of $8.12.
In the last year, Delcath Systems(DCTH) shares hit a 52-week high of $18.23 and a 52-week low of $8.12.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DCTH. This list is generated using Robinhood data, and it’s not a recommendation.